Policy Brief 71, January 2020
Major Outcomes of the 2019 World Health Assembly
By Mirza Alas and Nirmalya Syam
This policy brief provides an overview of the outcomes of selected agenda items that were discussed at the 72nd session of the World Health Assembly (WHA) of the World Health Organization (WHO), held from 21 to 26 May 2019 in Geneva. These items reflect some of the health priorities of developing countries.
Cette note de synthèse donne un aperçu des décisions adoptées concernant certains points de l’ordre du jour qui ont été examinés lors de la 72e session de l’Assemblée mondiale de la santé de l’Organisation mondiale de la santé (OMS), qui s’est tenue du 21 au 26 mai 2019 à Genève. Ces points reflètent certaines des priorités des pays en développement en matière de santé.
El presente informe de políticas ofrece una sinopsis de los resultados de determinados puntos del orden del día de la 72.ª Asamblea Mundial de la Salud de la Organización Mundial de la Salud (OMS), celebrada del 21 al 26 de mayo de 2019 en Ginebra. Estos puntos abordan algunas de las prioridades en materia de salud de los países en desarrollo.
Download the policy brief below:
Major Outcomes of the 2019 World Health Assembly
This article was tagged: Access to Medicines, Affordable Medicines, Antimicrobial Resistance (AMR), Flexibilities, Genetic Sequence Data (GSD), Innovation, Intellectual Property, Interagency Coordination Group (IACG), Mental Health, Non-Communicable Diseases (NCDs), Pandemic Influenza Preparedness (PIP) Framework, Primary Health Care (PHC), Research and Development (R&D), Sustainable Development Goals (SDGs), Transparency, TRIPS, Tuberculosis (TB), UN Secretary-General's High-Level Panel on Access to Medicines, United Nations General Assembly (UNGA), Universal Health Coverage (UHC), Vaccines, WHO Consultative Experts Working Group (CEWG), WHO Executive Board (EB), WHO Global Strategy (GSPOA), World Health Assembly (WHA), World Health Organization (WHO)
